Tanshinone I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC

• Autori principali: Jia Zhao (Autore), Hongbin Liu (Autore), Zhixian Hong (Autore), Wei Luo (Autore), Wenqing Mu (Autore), Xiaorong Hou (Autore), Guang Xu (Autore), Zhie Fang (Autore), Lutong Ren (Autore), Tingting Liu (Autore), Jincai Wen (Autore), Wei Shi (Autore), Ziying Wei (Autore), Yongping Yang (Autore), Wenjun Zou (Autore), Jun Zhao (Autore), Xiaohe Xiao (Autore), Zhaofang Bai (Autore), Xiaoyan Zhan (Autore)
• Natura: Libro
• Pubblicazione: BMC, 2023-07-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Abstract Background Abnormal activation of NLRP3 inflammasome is related to a series of inflammatory diseases, including type 2 diabetes, gouty arthritis, non-alcoholic steatohepatitis (NASH), and neurodegenerative disorders. Therefore, targeting NLRP3 inflammasome is regarded as a potential therape...